Page last updated: 2024-08-21

megestrol acetate and Cystadenocarcinoma, Papillary

megestrol acetate has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eltabbakh, GH; Garafano, LL; Hammond, JM; Moody, J	1

Other Studies

1 other study(ies) available for megestrol acetate and Cystadenocarcinoma, Papillary

Article	Year
The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma. European journal of gynaecological oncology, 1999, Volume: 20, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Paclitaxel; Prognosis; Treatment Outcome	1999

Article

Year

The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma.

European journal of gynaecological oncology, 1999, Volume: 20, Issue:1

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Paclitaxel; Prognosis; Treatment Outcome

1999